We hypothesized recently that arginine ho- established by medical history, physical examination, analysis of blood cell count, routine biochemical profile, and urinalysis. Their daily food and nutrient intakes were calculated to maintain body weight based on a dietary history and an estimate of the subject's usual level of physical activity. Subjects were encouraged to maintain their customary levels of physical activity but did not participate in competitive sports. The experimental protocol was approved by the Advisory Committee of the CRC. Subjects signed consent forms and were paid for their participation in the study.
feeding. The rates of conversion (pmol'kg-1-h-1; mean ± SD) of plasma argietoornthine forargine-rlchwere 12.9 ± 2.6 and 24.7 ± 4.8 for fast and fed states. These values were 11.1 ± 3.5 and 9.6 ± 1.2 (P > 0.05 and P < 0.001), respectively, with an arginifree diet.
[13C]Ornithine oxidation was reduced (P < 0.001) by 46% during the fed state when the ar -free diet was given. The finding strengthen our hypothesis that ofiarg O nne meta in the human host depends Importantly upon a regulation in the rate of arginin degradation with, perhaps, little involvement in the de novo net rate of argine synthesis.
Using stable-isotope tracer techniques, we have explored kinetic aspects of arginine metabolism in healthy adult humans (1, 2) , with a particular focus on the response ofarginine metabolism to dietary arginine restriction (3, 4) . From these studies, we have proposed that whole body arginine homeostasis is achieved largely by changes in the rate of arginine catabolism coupled to the dietary intake level (3) . This picture of arginine metabolism in vivo was developed from our findings that the plasma citrulline flux and rate of conversion of plasma [5,5-2H] citrulline to plasma [2Hiargin-ine were unaffected by giving subjects, for 6 days, a diet that was arginine-free (3) . We have now further examined this proposition by using specific tracers ofarginine and ornithine that permit us to estimate (i) the rates ofconversion ofplasma arginine to ornithine and (ii) the oxidation of ornithine and their responses to altered dietary arginine intakes. Our hypothesis was that these components of arginine and ornithine metabolism would be down-regulated when the dietary arginine supply was removed. In addition, we were also interested in developing an initial characterization of whole body ornithine kinetics in human subjects. This does not appear to have been attempted previously despite the importance of ornithine in creatine synthesis, in polyamine metabolism, and in the maintenance of body nitrogen homeostasis (5); aberrations in ornithine metabolism due to deficiencies of ornithine transcarbamylase (6) and ornitbine 8-aminotransferase (7) , for example, may lead to hyperammonemia with or without encephalopathy and loss of vision and blindness, respectively. The hypothesis that arginine degradation is a major determinant of body arginine balance under changing conditions ofarginine intake and metabolic need is supported by these observations.
MATERIALS AND METHODS Subjects and Experimental Desig. Six healthy adult males (means ± SD: age, 25 ± 3 yr; body weight, 80.5 ± 8.7 kg) participated in the study. They were investigated at the Clinical Research Center (CRC) of the Massachusetts Institute of Technology (MmT). All were in good health, as established by medical history, physical examination, analysis of blood cell count, routine biochemical profile, and urinalysis. Their daily food and nutrient intakes were calculated to maintain body weight based on a dietary history and an estimate of the subject's usual level of physical activity. Subjects were encouraged to maintain their customary levels of physical activity but did not participate in competitive sports. The experimental protocol was approved by the Advisory Committee of the CRC. Subjects signed consent forms and were paid for their participation in the study.
They consumed the arginine-rich (Arg-rich) diet for 6 days and on the morning of day 7 they received primed, constant intravenous tracer infusions of L-[guanidino-'5N2; 5,5- 2H]arginine and L- [5-13C] ornithine. This tracer study was followed immediately by a second 6-day experimental period during which an argnine-free (Arg-free) diet was consumed. Again, on the morning of day 7 an intravenous infusion protocol was conducted as described above. The experimental diet was based on isonitrogenous Arg-rich and Arg-free L-amino acid mixtures, as described (4). The major energy source was given in the form of protein-free wheat starch cookies. The daily intake, prior to the tracer infusion studies, was consumed as three separate meals at 0800, 1200, and 1700 h. Meals were prepared in the CRC by the dietary staff.
Tracer Infusion Studies. The isotope-infusion protocol lasted for 8 h. During the first 3 h, the subjects remained in the postabsorptive state (fast state), following their 10-to 12-h overnight fast. This phase was followed immediately by a 5-h fed state during which subjects received small, equal meals at 30-min intervals to supply over this period half of the amino acid intake received on the previous days. The details of procedures that were followed immediately before and during the infusion protocol have been presented (4, 8 It should be noted that in a recent study (L.C., T.E.C., A.A., and V.R.Y., unpublished results) in which [5,5- 2H]ornithine was given as a tracer, in an experiment similar to that described here, we detected the presence of a low but measurable level of [5- isotopolog. The origin of this M + 1 ornithine is presumably via the reversible ornithine aminotransferase reaction, during which L-glutamric-y-semialdehyde is formed, resulting in the loss of one 2H atom at the C-5 position (5 The ion clusters of all three tracers determined in the negative ion chemical ionization mode overlapped with the labeled products of the other tracers. Thus, a multiple linear regression approach was used to calculate the isotopic abundances of the amino acids from the mass spectrometry data, as has been explained in detail for isotopologs oftyrosine and leucine as tracers (10) . The concentrations of amino acids in the tracer infusates and in blood plasma were determined by high-performance liquid chromatography as described (4) .
In Vivo Model of Amino Acid Kinls. Plasma amino acid fluxes were calculated from the mean of the plasma isotopic enrichment values for the last 1 h of fast and the last 80 mm of the fed phases of the tracer period, using steady-state isotope dilution equations (1, 11) . The rate of conversion of plasma labeled arginine to ornithine (Qw.On) was determined essentially according to the tracer models of Clarke and Bier (12) and Thompson et al. (13) , where in these earlier cases they were used for measurement of conversion of labeled phenylalanine to tyrosine. Thus (13) .
The oxidation ofornithine (OrnoO) was determined by using the 13C abundance of plasma ornithine as the precursor (Ep). Rxx is a correction for incomplete recovery of 13C02 produced from ornithine oxidation in exhaled CO2. The factors that we have established in our laboratories used for this purpose were 0.766 and 0.851 for the fast and fed states, respectively (9) .
In previous studies, we measured plasma citrulline fluxes and found that they were not affected significantly by the level ofdietary arginine intake and did not differ between fast and fed conditions (3). Hence, although we did not determine directly the plasma citrulline fluxes in the present study, we did measure the appearance of [I3C]citrulline in plasma that was derived from infusion ofthe [13C]ornithine tracer. Therefore, an approximation of the rate of conversion of [13C] ornithine to plasma citrulline (Qoci) can be made from the present data by making the reasonable assumption that the mean citrulline flux in our subjects was 13 pmol kg-1-h-1 (3) and the determination based on the model described above, using data for plasma [13C]ornithine and [13C]citrulline isotopic abundances.
Evaluation of Data. Data were analyzed by a two-factor experiment with repeated measures on both factors. The analysis was treated as a subject by diet (Arg-free or Arg-rich) and by condition (fast or fed) factorial. When a significant diet by condition interaction was observed, the analyses were repeated separately for each condition and diets were compared. Plasma amino acids were compared by a paired t test. A value of P c 0.05 was considered to be statistically significant.
RESULTS AND DISCUSSION
The isotope abundances of plasma ornithine, arginine, and citrulline isotopologs during the quasi-steady-state metabolic conditions of the fast and fed periods are summarized in Table 1 . From these data and from those in Table 2 for unlabeled and labeled CO2 output (see also Fig. 1 showing a relatively steady state of 13C in expired air during fast and fed states), the plasma fluxes of these amino acids, the conver- sion rates of tracer arginine to ornithine and of ornithine to citrulline, and the rate of ornithine oxidation were calculated for subjects consuming the Arg-rich and Arg-free diets. These estimations are summarized in Table 3 .
The arginine flux during the fed phase was lowered significantly by giving subjects the Arg-free diet. Mean intake with the Arg-rich diet during the fed state was 41 pmol of arginine per kg per h. We estimated previously (2) an w38% "firstpass" disappearance ofdietary arginine within the splanchnic region; 62% of the dietary intake appears in the peripheral circulation. Thus, the difference (30 Mnol'kg'-h-1) between the fed-state arginine fluxes for the Arg-rich and Arg-free diet periods can be accounted for largely, if not entirely, by the expected decline of "'25 pmol kg-1 h-1 (41 x 0.62) in the rate of entry of dietary arginine into the peripheral circulation when an Arg-free diet is ingested.
The absolute values for plasma ornithine fluxes were lower than those for arginine (Table 3) . Also, we predicted, from our earlier tracer study (3) , that a restriction in the level of dietary arginine would lower the flux of ornithine. Also, this might be anticipated from Valle and Simell (5), who estimated that the daily ornithine aminotransferase flux equals "'400 ,umol-kg 1 (16 Pmol-kg-1h-1) for an adult consuming an Arg-rich diet and they consider the dietary intake of arginine to be largely responsible for this flux. The ornithine fluxes with [13C]ornithine were 28.4 ± 2.5 and 36.6 ± 3.5 amol kg-l h-1 for the fast and fed states, respectively, when subjects received the Arg-rich diet. They were reduced (P < 0.001 for fed state) by 11% and 36%, respectively, when the Arg-free diet was ingested. These differences probably reflect a lower rate of arginine catabolism by way of initial conversion to ornithine.
The above interpretation is supported by results for the isotopically derived estimates of the conversion of plasma arginine to ornithine (Table 3) ; these were 12.9 ± 2.6 and 24.7 ± 4.8 umollkg.li-1 for the Arg-rich fast and fed periods, respectively. They declined to 11.1 + 3.5 (P > 0.05) and 9.6 ± 1.2 nmolkg-1h-1 (P < 0.001) for the Arg-free fast and fed periods, respectively. This response indicates that when the dietary intake level of arginine is markedly reduced, the transfer ofplasma arginine to ornithine is diminished, helping to conserve body arginine, especially since the de novo synthesis rate is relatively low and apparently not markedly responsive to altered arginine intake (3, 4, 14) .
In parallel with the reduced rate of conversion of plasma labeled arginine to ornithine, especially in the fed state, the rate of [13C]ornithine oxidation was depressed when the Arg-free diet was given. For the Arg-rich diet group, mean rates of ornithine oxidation were estimated to be 6.5 and 14.4
pmol-kg-1h-' for fast and fed conditions, respectively.
These rates declined by 22% (P > 0.05) and 46% (P <.0.001) for fast and fed states when the Arg-free diet was ingested. Thus, we find evidence here of an adaptive decline in ornithine oxidation during the fed state, which parallels the decline in arginine flux.
The present estimates of the lowered rates of ornithine to citrulline conversion (Qo.cijt) ( Values are Wmoljkg-Lh-1 [mean ± SD (n = 6)]. * and **, different from fast (P < 0.01 and P < 0.001, respectively); t and tt, different from Arg-rich (P < 0.005 and P < 0.001, respectively) for the same condition (fast or fed).
and [5,5- (Table 4 ) and the diminished conversion of arginine to ornithine (Q ,) was accompanied by a lowered plasma free arginine concentration. In contrast, and as we have observed previously (3), plasma free citrulline was higher during the fed state when the Arg-free diet was consumed. Finally, plasma proline concentrations were higher at the end of the fed phase of the tracer study when subjects received the Arg-free vs. the Arg-rich diet. The possible importance of this difference between the two diets is discussed below.
Although the changes brought about by restricting dietary arginine intake in the rates of conversion of arginine to ornithine (QA.o) and of [13C]ornithine oxidation were parallel, there were quantitative differences. It is worthwhile, therefore, to examine closer the absolute rates and their relative changes, in reference to altered dietary arginine levels, and the summary given in Table 5 is made for this purpose.
The mean difference between the diet (Arg-rich, Arg-free) groups for QArg---Om during the fed state was 15.1 Amol kg-1'h-1 ( Table 5 ). The Arg-rich L-amino acid mixture supplied, during the infusion period, 41 pmol of arginine per kg per h, whereas there was none for the Arg-free diet.
Hence, a reduction of41 pmol kg-1 h-1 in the total intake was associated with a fall in Queen, equivalent to 37% of the total dietary supply during the fed period. However, the whole body response of QA,.om was probably greater than this, since not all of the dietary arginine enters the systemic blood compartment, or that which we sampled for isotopic determination (2) . Based on our recent studies involving simultaneous administration of stable nuclide-labeled arginine isotopologs via intravenous and intragastric routes, we can assume that 62% of the dietary input enters the systemic circulation and mixes with the plasma tracers (2) . Therefore, effectively, the systemic input of dietary arginine was 25
Hmolkg'h-1 (41 x 0.62). In this case, the estimated decline in QAgO amounts to =60% of the dietary input. In addition, there was also a small, mean reduction of 1.7 Amolkg-1*h-1 during the fast condition when the Arg-rich and Arg-free groups are compared (Table 4 ), although this difference did not reach statistical significance. From these estimates, it can be concluded that an Arg-free diet triggers a quantitatively significant adaptive decline in the rate of arginine degradation via its conversion to ornithine. The diminished rate of [13C]ornithine oxidation confirms this interpretation, but as summarized in Table 5 there are quantitative differences between these various measures ofin vivo arginine/ornithine metabolism; differences for the estimated rates of ornithine oxidation between the Arg-rich and Argfree experimental periods were not as great as those for
Qorn
The apparently smaller change in the rate of [13Cjornitbine oxidation due to feeding of an Arg-free diet, in comparison with the change in Qror,, might be explained by considering the composition of the Arg-rich and Arg-free L-amino acid mixtures used in the experimental diets. To keep the intake of total dietary nitrogen constant among the two diet groups, we formulated the mixtures to contain the same amount (per unit weight) of nitrogen, together with the same concentrations of the individual, nutritionally indispensable amino acids. Hence, the nutritionally dispensable amino acids had to be adjusted to achieve this goal and so the proline and glycine contents of the Arg-free mixture were higher and the glutamate content was lower than that for the Arg-rich mixture (4) . Because the oxidation of ornithine and proline each involves their conversion to glutamic-y-semialdehyde (the uncyclized tautomer with which pyrroline-5-carboxylate is in spontaneous equilibrium and which is an intermediate common to both synthetic and degradative pathways of proline), the higher proline intake could alter, in complex ways, the relationships between the in vivo oxidation rates of
[13C]ornithine and proline and the 13C isotopic abundances of the labeled intermediates linking the synthesis and degrada- Values are means ± SD. Values for differences are expressed as ,umol-kg-1-h-1.
tion ofproline, ornithine, glutamate, which occur in the intraand extramitochondrial regions of the cell and presumably to various degrees and in relative amounts in different organs (5) , and expired CO2. Also, as noted above, the plasma proline concentration was higher at the end of the 5-h fed phase of the tracer study when the Arg-free diet was given to the subjects. Hence, until the metabolic interactions in vivo between proline, ornithine, and arginine kinetics and their rates of degradation are more completely defined, and better understood, the [13C]ormithine oxidation data should be taken to be an approximate quantitative measure of the net rate of arginine degradation and ofthe metabolic response to dietary arginine restriction.
In conclusion, we have demonstrated in healthy adult humans a reduced rate of conversion of arginine to ornithine and ofornithine oxidation when the dietary supply ofarginine is removed. These findings support our concept that whole body arginine homeostasis is achieved principally via modulation in the rate of arginine degradation (3). We must now learn whether this component of arginine metabolism is affected primarily by the level of substrate supply and/or by changes in the activities of the different isoforms of arginase and of ornithine aminotransferase (5, (15) (16) (17) . The potential significance of substrate supply is suggested by the relatively high Km values for these enzymes, in comparison with the concentrations shown in Table 4 for plasma arginine and ornithine. The latter might be taken as first approximations of the concentrations of the amino acids at the active site of the enzymes. Thus, for arginase the K., is 10 mM (5) and for ornithine aminotransferase the KnX is 1.8 mM, implying that these enzymes are not usually saturated under normal physiological conditions, although we appreciate that an adequate understanding of the in vivo mechanisms of metabolic regulation demands a more comprehensive consideration of the components and external regulators of the metabolic pathway of interest (18) . Finally, we plan to carry out long-term dietary-restriction metabolic studies to assess whether further significant alterations occur in arginine-ornithine metabolic interrelations and especially during the fast state.
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